Jian-di Wang, Yi-Wei Wang, Jia-Xin Wu, Zhi-Xiong Shi
School of Public Health,Capital Medical University,Beijing 100069,China.
Shunyi Maternal and Children's Hospital of Beijing Children's Hospital,Beijing 101300,China.
Se Pu. 2025 Jul;43(7):756-766. doi: 10.3724/SP.J.1123.2024.11028.
Per- and polyfluoroalkyl substances (PFASs) are a large group of synthetic chemicals that have been widely used in various industrial and commercial products owing to their unique physicochemical properties. However, accumulating evidence suggests that PFASs are persistent, transmissive over long distances, bioaccumulative, and toxic; consequently, their adverse effects on ecosystems and humans is of widespread concern. Serum is the most commonly used human matrix for assessing internal exposure to environmental pollutants, and several analytical methods have been developed to measure PFASs in sera. Current methods are generally fast, convenient, and robust; however, their pretreatment steps require large amounts of organic solvents and materials, such as solid-phase extraction cartridges and/or sorbents. In this study, a novel and low-cost analytical method based on cold-induced phase separation (CIPS) strategy was developed for the simultaneous determination of 31 legacy and emerging PFASs in serum. The core mechanism and distinctive feature of CIPS involves cooling an acetonitrile-water (ACN-water) mixture at a low temperature to produce two clear-cut layers: one with a high ACN proportion (the ACN layer) and an aqueous layer (water layer). Certain chemicals are significantly enriched in the ACN layer during cooling; at the same time, impurities, especially water-soluble impurities, remain in the aqueous layer. CIPS only requires the temperature to be varied, and no external impurities are introduced during pretreatment, which dramatically reduces material costs and avoids new impurities from intervening. Our method involves the following procedure: serum was drawn accurately (0.2 mL) into a 1.5 mL Eppendorf (EP) tube, 2 ng of each isotopically labeled internal standard was added, the mixture is vortexed, and 350 µL of ACN was added, followed by vortexing and ultrasonic extraction. Subsequently, 450 µL of water is added to adjust the volume proportion of ACN to 35% (the volume percentage of ACN in the total solution). The protein at the bottom of the tube was collected following centrifugation at 15 000 r/min for 10 min, and the supernatant was transferred to a 1 mL syringe. The syringe was frozen in a -20 ℃ refrigerator for 1 h to obtain the two layers, after which the upper layer (approximately 80-100 μL) containing ACN and the target compounds was finally transferred to a glass vial for instrumental analysis. Liquid chromatography coupled with triple quadrupole mass spectrometry augmented with electrospray ionization (LC-ESI-MS/MS) was used to quantify the PFASs. The analytes were separated using a C18 column, with methanol and 2 mmol/L of ammonium formate-HO used as mobile phases. Linearities, limits of detection (LODs) and, limits of quantification (LOQs), recoveries, precisions, and matrix effects were determined under the optimal conditions. The LODs and LOQs of PFASs in serum were 0.01-25 and 0.03-83 pg/mL, respectively. Under two spiked levels, namely 5 ng/mL and 25 ng/mL, average recoveries ranged between 60.5% and 129.6%, with relative standard deviations (RSDs) of less than 22.8%. Under 5 pg/mL as LOD spiked level, average recoveries ranged between 61.6% and 199.1%,with RSDs<29.4%. While matrix-effect testing revealed slightly enhanced signals, the use of isotopically labeled internal standards compensated for these effects. Real samples were subsequently analyzed, with 50 human serum samples collected in first trimester of pregnancy women living in the Shunyi District, Beijing. Nine PFASs exhibited high detection frequencies (>80%), which suggests that PFASs are ubiquitous in the population. The median and mean levels of ΣPFASs (sum of 31 PFASs) in serum were 21.8 and 22.9 ng/mL, respectively, and the range was 0.456-73.9 ng/mL. Both legacy and emerging PFASs were detected at high frequencies and contamination levels, which suggests that they are widely used. In summary, the method developed in this study is fast, sensitive, and solvent- and material-efficient; it is also very linear and highly accurate, and exhibits satisfactory extraction recovery and enrichment factors; hence, it is suitable for surveying large populations as well as for use in environmental epidemiology.
全氟和多氟烷基物质(PFASs)是一大类合成化学品,由于其独特的物理化学性质,已广泛应用于各种工业和商业产品中。然而,越来越多的证据表明,PFASs具有持久性、长距离迁移性、生物累积性和毒性;因此,它们对生态系统和人类的不利影响受到广泛关注。血清是评估人体内部环境污染物暴露最常用的样本,已经开发了几种分析方法来测量血清中的PFASs。目前的方法通常快速、方便且稳健;然而,其预处理步骤需要大量有机溶剂和材料,如固相萃取柱和/或吸附剂。在本研究中,基于冷诱导相分离(CIPS)策略开发了一种新颖且低成本的分析方法,用于同时测定血清中31种传统和新型PFASs。CIPS的核心机制和独特特征是在低温下冷却乙腈-水(ACN-水)混合物,产生两个清晰的层:一个是ACN比例高的层(ACN层)和一个水层(水层)。某些化学物质在冷却过程中会在ACN层中显著富集;同时,杂质,特别是水溶性杂质,会留在水层中。CIPS只需要改变温度,预处理过程中不引入外部杂质,这大大降低了材料成本,避免了新杂质的干扰。我们的方法包括以下步骤:准确吸取0.2 mL血清至1.5 mL Eppendorf(EP)管中,加入每种同位素标记内标2 ng,涡旋混合,加入350 μL ACN,再涡旋和超声提取。随后,加入450 μL水将ACN的体积比例调整为35%(ACN在总溶液中的体积百分比)。以15000 r/min离心10 min,收集管底部的蛋白质,将上清液转移至1 mL注射器中。将注射器在-20℃冰箱中冷冻1 h以获得两层,最后将含有ACN和目标化合物的上层(约80-100 μL)转移至玻璃小瓶中进行仪器分析。采用液相色谱-串联三重四极杆质谱联用仪(LC-ESI-MS/MS)对PFASs进行定量。使用C18柱分离分析物,以甲醇和2 mmol/L甲酸铵-H2O作为流动相。在最佳条件下测定线性、检测限(LODs)、定量限(LOQs)、回收率、精密度和基质效应。血清中PFASs的LODs和LOQs分别为0.01-25和0.03-83 pg/mL。在两个加标水平下,即5 ng/mL和25 ng/mL,平均回收率在60.5%至129.6%之间,相对标准偏差(RSDs)小于22.8%。在以5 pg/mL作为LOD的加标水平下,平均回收率在